RxSight Inc [RXST] stock prices are up 2.01% to $11.65 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The RXST shares have gain 14.78% over the last week, with a monthly amount glided 35.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on July 15, 2025, when Morgan Stanley downgraded its rating to a Equal-Weight but kept the price target unchanged to $9 for it. Previously, Jefferies downgraded its rating to Hold on July 10, 2025, and kept the price target unchanged to $9. On July 09, 2025, downgrade downgraded it’s rating to Equal Weight but maintained its price target of $9 on the stock. Oppenheimer downgraded its rating to a Perform. BTIG Research downgraded its rating to a Neutral. Wells Fargo upgraded its rating to Overweight for this stock on May 19, 2025, but kept the price target unchanged to $25. In a note dated April 15, 2025, Piper Sandler initiated an Neutral rating and provided a target price of $18 on this stock.
The stock price of RxSight Inc [RXST] has been fluctuating between $6.32 and $47.89 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $11.65 at the most recent close of the market. An investor can expect a potential drop of -14.16% based on the average RXST price forecast.
Analyzing the RXST fundamentals
The RxSight Inc [NASDAQ:RXST] reported sales of 142.09M for trailing twelve months, representing a drop of -14.09%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at -0.27%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.21%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.12 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.30 points at the first support level, and at 10.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.90, and for the 2nd resistance point, it is at 12.15.
Ratios To Look Out For
It’s worth pointing out that RxSight Inc [NASDAQ:RXST]’s Current Ratio is 12.74. On the other hand, the Quick Ratio is 11.44, and the Cash Ratio is 1.98. Considering the valuation of this stock, the price to sales ratio is 3.37, the price to book ratio is 1.73.
Transactions by insiders
Recent insider trading involved Fountain Tamara, Director, that happened on Mar 12 ’25 when 7000.0 shares were sold. Director, TAMARA R FOUNTAIN completed a deal on Mar 12 ’25 to buy 7000.0 shares. Meanwhile, Director Maniar Shweta sold 3519.0 shares on Jan 22 ’25.
